JD.com Inc (JDCO34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 22.35 |
|---|---|
| 52-week range | 21.06 – 31.21 |
| Return, 1 month / 3 months | −2.7% / −14.8% |
| Return, 1 year / 3 years | −24.4% / +13.8% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 34.0% |
| Worst drawdown (1 year) | -29.5% |
| Average daily value traded | 0.09M BRL |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
JD.com is a Chinese e-commerce company based in Beijing. It runs an online retail platform where customers buy electronics, household goods, apparel and groceries, and it also lets third-party merchants trade through its marketplace. The company operates its own logistics and delivery network to fulfil orders, and it offers related services such as advertising and fulfilment support to merchants. Its customers are mainly consumers in China, along with brands and retailers that use its platform and supply chain.
JD.com Inc is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code JDCO34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
JD.com Inc (JDCO34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 22.35 on 27 October 2026.
Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 1,091 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 24.4% and over the last three months it fell 14.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.1% | ||
| From 52-week high | -27.5% | ||
| Momentum | 15 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.8% | ||
| 6-month return | -15.9% | ||
| 12-month return, skipping the last month | -22.3% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.5% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.09M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 31 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | −2.7% |
| 3 months | −14.8% |
| 6 months | −15.9% |
| 1 year | −24.4% |
| 3 years | +13.8% |
| 5 years | −62.1% |
Signals
| 50-day / 200-day average | 23.36 / 24.32 |
|---|---|
| Golden / death cross (60 days) | Death, 11 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.73 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Apr 2026 | CNY 0.7873 |
| 4 Apr 2025 | CNY 0.8934 |
| 3 Apr 2024 | CNY 0.6163 |
| 4 Apr 2023 | CNY 0.4802 |
| 18 May 2022 | CNY 6.1245 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.